Hospital-wide access to genomic data advanced pediatric rare disease research and clinical outcomes
Open Access
- 2 December 2024
- journal article
- research article
- Published by Springer Nature in npj Genomic Medicine
- Vol. 9 (1) , 1-11
Abstract
Boston Children’s Hospital has established a genomic sequencing and analysis research initiative to improve clinical care for pediatric rare disease patients. Through the Children’s Rare Disease Collaborative (CRDC), the hospital offers CLIA-grade exome and genome sequencing, along with other sequencing types, to patients enrolled in specialized rare disease research studies. The data, consented for broad research use, are harmonized and analyzed with CRDC-supported variant interpretation tools. Since its launch, 66 investigators representing 26 divisions and 45 phenotype-based cohorts have joined the CRDC. These studies enrolled 4653 families, with 35% of analyzed cases having a finding either confirmed or under further investigation. This accessible and harmonized genomics platform also supports additional institutional data collections, research and clinical, and now encompasses 13,800+ patients and their families. This has fostered new research projects and collaborations, increased genetic diagnoses and accelerated innovative research via integration of genomics research with clinical care.Keywords
Funding Information
- Institutional funding from Boston Children's Hospital
This publication has 40 references indexed in Scilit:
- Utility of Exome Sequencing for Diagnosis in Unexplained Pediatric-Onset EpilepsyJAMA Network Open, 2023
- Exome Sequencing Expands the Genetic Diagnostic Spectrum for Pediatric Hearing LossThe Laryngoscope, 2022
- Mendelian Disorders in an Interstitial Cystitis/Bladder Pain Syndrome CohortAdvanced Genetics, 2022
- Mendelian etiologies identified with whole exome sequencing in cerebral palsyAnnals of Clinical and Translational Neurology, 2022
- Project Baby Bear: Rapid precision care incorporating rWGS in 5 California children’s hospitals demonstrates improved clinical outcomes and reduced costs of careThe American Journal of Human Genetics, 2021
- Feasibility of Ultra-Rapid Exome Sequencing in Critically Ill Infants and Children With Suspected Monogenic Conditions in the Australian Public Health Care SystemJAMA, 2020
- A Randomized, Controlled Trial of the Analytic and Diagnostic Performance of Singleton and Trio, Rapid Genome and Exome Sequencing in Ill InfantsThe American Journal of Human Genetics, 2019
- Whole genome sequencing reveals that genetic conditions are frequent in intensively ill childrenIntensive Care Medicine, 2019
- Data Analysis2016
- The Matchmaker Exchange: A Platform for Rare Disease Gene DiscoveryHuman Mutation, 2015